EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Charlotte's Web Holdings (CWBHF) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of Charlotte's Web Holdings $0.65, price $0.27, upside +140.7%, quality 33 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? No
  3. Add to watchlist

Healthcare · US · Home Canada · ISIN CA16106R1091

CS Charlotte's Web Holdings logo Thin data Jun 23, 2026

Charlotte's Web Holdings

CWBHF · US

Cheap, value-trap riskThe stock looks deeply undervalued, but low quality raises value-trap risk.

✓Fair value $0.6500 · Strongly undervalued (+140.7%)
!Quality 33/100
!Weak Growth (revenue 5y −12.1 %/yr)
!Loss-making · -75.1% net margin (TTM)
!Negative equity (buybacks among others) · negative free cash flow
!Narrow moat 6/100
!Evidence only low, so the estimate is less certain

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$3.69 $0.0600 Fair Value $0.6500 Jul 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jun 23, 2026.

How to read this chart

60‑month range $0.0600 – $3.69 · fair‑value band $0.4800 – $0.8100 · the $0.2700 price screens below the $0.6500 fair value. Dashed = 300-day average. As of Jun 23, 2026.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Charlotte's Web Holdings, Inc. engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and botanical-based wellness products in the United States.

Show more

Charlotte's Web Holdings, Inc. engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and botanical-based wellness products in the United States. The company offers full-spectrum hemp extract oil tinctures, such as liquid products; gummies; capsules; soft-gels; CBD topical creams and lotions; broad-spectrum botanical CBD; functional mushroom gummies; and pet products. Its products contain naturally occurring phytocannabinoids, including CBD, cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), terpenes, flavonoids, and other beneficial hemp compounds. The company markets its products under the Charlotte's Web, Brightside, CBD Clinic, and CBD Medic brands. It distributes its products through its e-commerce website, third-party e-commerce websites, distributors, retailers, and healthcare practitioners. The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte's Web Holdings, Inc. in July 2018. Charlotte's Web Holdings, Inc. was founded in 2013 and is headquartered in Louisville, Colorado.

Stock analysis

Charlotte's Web Holdings (CWBHF) currently trades at $0.2700, while our model-based Fair Value estimate is $0.6500, implying the stock looks roughly 58.5% undervalued today.

Show more

Valuation

How firm this estimate is: it rests on 3 models at a data quality of 95/100, which puts the evidence level at low.

Scenario range: $0.4800 (bear) to $0.8100 (bull), the price of $0.2700 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 33/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue growth is weak: less than 2 % a year.

Charlotte's Web Holdings reported revenue of $49.9M in FY2025 versus $96.1M in FY2021, a compound −15.1%/yr. Reported net income was −$29.7M in FY2025.

Key figures

Market cap $81.4M · P/S ratio 1.67 · EPS (TTM) $−0.2300 · Net margin −59.6% · Return on equity −1,217% · Return on assets (EBIT) −39.0% · Operating margin −38.8% · Revenue (TTM) $48.8M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (low confidence).

What moves the price

The share trades about 71% below its 52-week high and 218% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −19% fair-value upside, at 141%, CWBHF screens cheaper than that median.

Notify me when CWBHF reaches fair value

Put CWBHF on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 33/100

Of which business quality 31 · Market factors (momentum, volatility) 35

Profitability 24
Margins and returns on capital today
Quality Growth 35
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 12
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 0
Calm price path (market factor)
Momentum 42
Price trend over the last 3–12 months (market factor)
52W Momentum 61
Distance to the 52-week high (market factor)
Net Issuance 57
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 6/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
+0.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−12.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−12.1%
Start year 2020 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.5%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−55.1% (2020) → −40.6% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch CWBHF, get fair value alerts →

Compare Charlotte's Web Holdings with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Merck KGaA MRK €134.45 €108.94 −19%
Takeda Pharmaceutical Company TAK $18.90 $11.45 −39%
Teva Pharmaceutical Industries Limited TEVA $39.31 $20.88 −47%
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,852 ₹1,979 +7%
Galderma Group GALD CHF 163.00 CHF 110.32 −32%
Jiangsu Hengrui Pharmaceuticals Co 600276 ¥44.86 ¥49.35 +10%
Haleon plc HLN $9.26 $8.49 −8%
Sandoz Group SDZ CHF 71.16 CHF 40.32 −43%
Zoetis Inc ZTS $70.30 $110.50 +57%
Divi's Laboratories Limited DIVISLAB ₹9,620 ₹1,871 −81%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Charlotte's Web Holdings · Fair Value
$0.6500 +58%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Charlotte's Web Holdings Fair Value". https://www.fairvalue-calculator.com/stock/CWBHF

Frequently asked questions

Is Charlotte's Web Holdings (CWBHF) overvalued or undervalued?
As of Jun 23, 2026, our model estimates a fair value of $0.6500 versus a price of $0.2700, about +141% upside (undervalued).
What is the fair value of CWBHF?
Our model-based fair value for Charlotte's Web Holdings is $0.6500 (as of Jun 23, 2026), built from audited fundamentals. The current price: $0.2700.
What is the quality score of CWBHF?
Charlotte's Web Holdings has a Quality Score of 33/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Charlotte's Web Holdings (CWBHF)?
Our model-based price target is the fair value of $0.6500 (as of Jun 23, 2026) from 3 valuation models. Cautious scenario $0.4800, optimistic scenario $0.8100. It is a calculation from audited fundamentals, not an analyst target.
What is the Charlotte's Web Holdings stock forecast for 2026?
Our models put fair value at $0.6500, about +141% upside versus a price of $0.2700 (undervalued). Cautious scenario $0.4800, optimistic scenario $0.8100. The calculation is refreshed regularly with new filings.
What is the revenue of Charlotte's Web Holdings (CWBHF)?
Charlotte's Web Holdings reported trailing-twelve-month revenue of about $48.8M (latest available figure, as of Jun 23, 2026).
What is the intrinsic value of Charlotte's Web Holdings (CWBHF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Charlotte's Web Holdings it is $0.6500 per share (as of Jun 23, 2026), against a price of $0.2700. It is the blended result of 3 valuation models (cash flow, earnings, asset, dividend).
Is Charlotte's Web Holdings stock overvalued or undervalued in 2026?
As of Jun 23, 2026, CWBHF trades below its calculated fair value: price $0.2700, fair value $0.6500, a gap of about +141% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CWBHF?
No. The price is what the market pays today ($0.2700); the fair value is what the company's own numbers justify ($0.6500). For Charlotte's Web Holdings the two are $0.3800 per share apart. That gap is exactly why we show both numbers side by side.
How much is Charlotte's Web Holdings worth?
The market values Charlotte's Web Holdings at about $81.4M (market capitalisation, as of Jun 23, 2026). Per share that is $0.2700; our models calculate a fair value of $0.6500 per share.
What do the bullish and bearish scenarios say about CWBHF?
Our models span a range for Charlotte's Web Holdings: cautious scenario $0.4800, base $0.6500, optimistic $0.8100 per share (as of Jun 23, 2026, price $0.2700). The range comes from different growth and margin assumptions, not from analyst opinions.
How far is CWBHF from its 52-week high?
Charlotte's Web Holdings trades at $0.2700, about 71% below its 52-week high of $0.9200 and 218% above the low of $0.0850 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of $0.6500 is for.
Which stocks are comparable to Charlotte's Web Holdings?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Charlotte's Web Holdings stock attractive at the current price?
The data as of Jun 23, 2026: price $0.2700, calculated fair value $0.6500 (+141%), Quality Score 33/100, from 3 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CWBHF calculated?
We run Charlotte's Web Holdings through 3 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.6500, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Charlotte's Web Holdings currently trades 58 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Charlotte's Web Holdings (CWBHF)?
The closing price on Oct 2, 2026 was $0.2700. Our model-based fair value is $0.6500, about +141% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Charlotte's Web Holdings right now?
The large discount to fair value meets weak quality (33/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case ($0.4800). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Charlotte's Web Holdings

How large is the market capitalisation of Charlotte's Web Holdings (CWBHF)?
The market capitalisation of Charlotte's Web Holdings is $81.4M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Charlotte's Web Holdings (CWBHF)?
The price-to-sales ratio of Charlotte's Web Holdings is 1.67 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Charlotte's Web Holdings (CWBHF)?
Earnings per share at Charlotte's Web Holdings are $−0.2300. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Charlotte's Web Holdings (CWBHF)?
The net margin of Charlotte's Web Holdings is −59.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Charlotte's Web Holdings (CWBHF)?
The return on equity (ROE) of Charlotte's Web Holdings is −1,217% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Charlotte's Web Holdings (CWBHF)?
On an EBIT basis the return on assets of Charlotte's Web Holdings is −39.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Charlotte's Web Holdings (CWBHF)?
The operating margin of Charlotte's Web Holdings is −38.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Charlotte's Web Holdings (CWBHF)?
Revenue at Charlotte's Web Holdings is growing −9.0% versus a year earlier (3y avg −12.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Charlotte's Web Holdings (CWBHF) generate?
The free cash flow of Charlotte's Web Holdings is −$14.7M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Continue in the live analysis

Fair value and trend for 35,000+ stocks, watchlist, comparison and the diversification check. You can also try 14 days of Pro there, no card.

Open the live analysis →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.